Page last updated: 2024-08-16

zolpidem and paroxetine

zolpidem has been researched along with paroxetine in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.11)18.2507
2000's8 (44.44)29.6817
2010's8 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H1
Lombardo, F; Obach, RS; Waters, NJ1
Ahman, M; Holmén, AG; Wan, H1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Katz, SE1
Meyer, C1
de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P1
Blin, D; Derderian, F; Durand, M; Gonthier, YT; Mongenot, F1
Chen, ZQ; Ji, JL; Liu, WJ; Mei, QY; Pan, JY; Tao, M; Wang, YP; Wei, J; Zhang, N; Zhao, ZX; Zheng, AL1
Chaslerie, A; Feuillet, F; Hardouin, JB; Jolliet, P; Pivette, J; Sébille, V; Victorri-Vigneau, C; Wainstein, L1
Liu, Y; Mao, HJ; Song, MF; Tang, GZ; Wang, SD; Xu, XH; Yin, Y; Yu, ZH1

Reviews

2 review(s) available for zolpidem and paroxetine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pharmacotherapy of aphasia: myth or reality?
    Brain and language, 2007, Volume: 102, Issue:1

    Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem

2007

Trials

2 trial(s) available for zolpidem and paroxetine

ArticleYear
[Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study].
    Zhonghua yi xue za zhi, 2007, Jun-19, Volume: 87, Issue:23

    Topics: Antidepressive Agents, Second-Generation; Depression; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Outcome Assessment, Health Care; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Zolpidem

2007
Effect and safety of paroxetine combined with zolpidem in treatment of primary insomnia.
    Sleep & breathing = Schlaf & Atmung, 2017, Volume: 21, Issue:1

    Topics: Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Pyridines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Wakefulness; Zolpidem

2017

Other Studies

14 other study(ies) available for zolpidem and paroxetine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
    Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19

    Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Possible paroxetine-zolpidem interaction.
    The American journal of psychiatry, 1995, Volume: 152, Issue:11

    Topics: Adolescent; Delirium; Drug Interactions; Female; Humans; Hypnotics and Sedatives; Paroxetine; Pyridines; Zolpidem

1995
New drugs. In the realm of the brain.
    The American journal of nursing, 1993, Volume: 93, Issue:8

    Topics: Central Nervous System Agents; Depression; Humans; Hypnotics and Sedatives; Migraine Disorders; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Sumatriptan; Zolpidem

1993
[Treatment of hydroxychloroquine poisoning with extracorporeal circulation].
    Annales francaises d'anesthesie et de reanimation, 2007, Volume: 26, Issue:2

    Topics: Adult; Antidotes; Bromazepam; Charcoal; Coma; Combined Modality Therapy; Diazepam; Drug Overdose; Epinephrine; Extracorporeal Circulation; Female; Fluid Therapy; Gastric Lavage; Heart Massage; Humans; Hydroxychloroquine; Hypokalemia; Paroxetine; Plasma Substitutes; Potassium; Pyridines; Shock, Cardiogenic; Sodium Channel Blockers; Suicide, Attempted; Vasoconstrictor Agents; Ventricular Fibrillation; Zolpidem

2007
Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.
    International clinical psychopharmacology, 2011, Volume: 26, Issue:1

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Bromazepam; Databases, Factual; Drug Utilization; France; Humans; Hypnotics and Sedatives; Paroxetine; Pyridines; Risk; Substance-Related Disorders; Zolpidem

2011